(Q48698266)

14 February 2018

title

Enzymatic characteristics of CYP3A5 and CYP3A4: a comparison of in vitro kinetic and drug-drug interaction patterns. (English)

1 reference

14 February 2018

0 references

Emoto C

1

1 reference

14 February 2018

Iwasaki K

series ordinal

2

1 reference

14 February 2018

language of work or name

English

0 references

publication date

1 February 2006

1 reference

14 February 2018

published in

Xenobiotica

1 reference

14 February 2018

volume

36

1 reference

14 February 2018

issue

2-3

1 reference

14 February 2018

page(s)

219-233

1 reference

14 February 2018

Involvement of CYP3A in the metabolism of eplerenone in humans and dogs: differential metabolism by CYP3A4 and CYP3A5.

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00498250500489968

Phenylalanine and tryptophan scanning mutagenesis of CYP3A4 substrate recognition site residues and effect on substrate oxidation and cooperativity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250500489968

In vitro inhibitory effect of 1-aminobenzotriazole on drug oxidations catalyzed by human cytochrome P450 enzymes: a comparison with SKF-525A and ketoconazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250500489968

In vitro inhibitory effect of 1-aminobenzotriazole on drug oxidations in human liver microsomes: a comparison with SKF-525A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250500489968

Multisite kinetic analysis of interactions between prototypical CYP3A4 subgroup substrates: midazolam, testosterone, and nifedipine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250500489968

Cytochrome P-450 3A4: regulation and role in drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250500489968

CYP3A4 drug interactions: correlation of 10 in vitro probe substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250500489968

Interindividual variability and tissue-specificity in the expression of cytochrome P450 3A mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250500489968

Fetus-specific expression of a form of cytochrome P-450 in human livers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250500489968

Extrahepatic metabolism of drugs in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250500489968

Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250500489968

Evaluation of approach to predict the contribution of multiple cytochrome P450s in drug metabolism using relative activity factor: effects of the differences in expression levels of NADPH-cytochrome P450 reductase and cytochrome b(5) in the expressi

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250500489968

In vitro metabolism of midazolam, triazolam, nifedipine, and testosterone by human liver microsomes and recombinant cytochromes p450: role of cyp3a4 and cyp3a5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250500489968

Substrate dependent inhibition profiles of fourteen drugs on CYP3A4 activity measured by a high throughput LCMS/MS method with four probe drugs, midazolam, testosterone, nifedipine and terfenadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250500489968

Summary of information on human CYP enzymes: human P450 metabolism data

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250500489968

Activation of CYP3A4: evidence for the simultaneous binding of two substrates in a cytochrome P450 active site.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250500489968

Clinical importance of hepatic cytochrome P450 in drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250500489968

Cooperativity in oxidations catalyzed by cytochrome P450 3A4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250500489968

Structure-function relationships of human liver cytochromes P450 3A: aflatoxin B1 metabolism as a probe

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250500489968

Cloning and tissue distribution of a novel human cytochrome p450 of the CYP3A subfamily, CYP3A43.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250500489968

The human hepatic cytochromes P450 involved in drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250500489968

P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250500489968

Alanine-scanning mutagenesis of a putative substrate recognition site in human cytochrome P450 3A4. Role of residues 210 and 211 in flavonoid activation and substrate specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250500489968

Molecular modelling of CYP3A4 from an alignment with CYP102: identification of key interactions between putative active site residues and CYP3A-specific chemicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250500489968

10.1080/00498250500489968

21 January 2018

Identifiers

DOI

1 reference

14 February 2018

1 reference

14 February 2018